Ann: Preliminary Final Report-AJX.AX, page-62

Well I've bought some more this morning. Will probably buy some more tomorrow too. Some people might be scared by the $15m accounting loss, or the build up in operating expenses without much revenue growth, but I'm not. The issue and option exercises have kept cash levels static so that relieves any issue pressure and as the company has frequently stated, it all starts to happen revenue wise from about now.

I like the build up in sales leads, pipeline, scale up and the retention rate. I really liked that they are poised to announce licensing contracts with major chemical companies for Alexiflam, and sounds like Alexicool is another "must have" technology. With many of my other stocks looking tired, I'm guessing AJX has better chances of providing some positive surprises in the next twenty four months than most others, and it just might exceed even its own expectations!